🧫

Nation-wide NGS-based genetic screening of LGMD patients in US

active
experiment Created: 2026-04-10T23:12:20 By: experiment_extractor Quality: 95% ✓ SciDEX ID: experiment-exp-016edb6e-a692-4df5-a2ca-b
🧫 Experiment Protocol Genetic Associationproposed
N = 4656
Related Entities
CAPN3, DYSF, FKRP, ANO5, DNAJB6
Metadata
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T23:12:20.326102'}
p_valueNone
protocolNext-generation sequencing (NGS)-based gene panel testing of 35 LGMD-associated or LGMD-like NMD-associated genes conducted in CLIA-CAP certified Emory Genetics Laboratory over 2-year recruitment peri
effect_sizeNone
sample_size4656
source_pmid30564623
extracted_at2026-04-10T16:12:20.323398
_schema_version1
experiment_typegenetic_association
success_criteriaMolecular diagnosis establishment and gene variant identification in clinically suspected LGMD patients
expected_outcomesDetermine relative prevalence of LGMD subtypes, establish diagnostic yield, and characterize genetic etiology in US population
statistical_methodsConfidence intervals calculated for diagnostic yield
📊 Evidence Profile Foundational
Evidence Balance
+0%
Certainty
80%
Debates
0
Incoming
16
Outgoing
9
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.